According to Uttar Pradesh Drug Licensing and Control officer A K Jain, the company has given compensation to three patients who had undergone revision surgeries for the faulty implants made by the company.
The Delhi High Court had in May directed Johnson and Johnson to make an interim payment of Rs 25 lakh each to the 67 patients who have undergone revision surgeries.
Jain said the Uttar Pradesh Drug Licensing and Control Authority was promptly following such complaints. PTI ABN DPB
Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI